An evaluation of the TREC assay with regard to the integration of SCID screening into the Dutch newborn screening program

Clinical Immunology

Volumn 180, Issue , 2017, Pages 106-110

  Blom, Maartje ^a   Pico Knijnenburg, Ingrid ^b   Sijne van Veen, Marja ^c   Boelen, Anita ^c   Bredius, Robbert G M ^d   van der Burg, Mirjam ^b   Schielen, Peter C J I ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Heel prick cards; Newborn screening; Severe combined immunodeficiency; T cell receptor excisions circles; TREC; deleting recombination excision circles

Indexed keywords

ARTICLE; ASSAY; CONTROLLED STUDY; DIAGNOSTIC EQUIPMENT; DRIED BLOOD SPOT TESTING; EVALUATION STUDY; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; NETHERLANDS; NEWBORN; NEWBORN SCREENING; POLYMERASE CHAIN REACTION; PREMATURITY; PRIORITY JOURNAL; SEVERE COMBINED IMMUNODEFICIENCY; T CELL RECEPTOR EXCISION CIRCLES ASSAY; BIOASSAY; BLOOD; GENETICS; IMMUNOLOGY; PROCEDURES;

CIRCULAR DNA; LYMPHOCYTE ANTIGEN RECEPTOR;

BIOLOGICAL ASSAY; DNA, CIRCULAR; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NEONATAL SCREENING; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 85019268862     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2017.05.007     Document Type: Article

References (21)

1. Buelow, B.J., Routes, J.M., Verbsky, J.W., Newborn screening for SCID: where are we now?. Expert. Rev. Clin. Immunol., 2015.
2. Somech, R., et al. Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study. Isr. Med. Assoc. J. 15 (2013), 404–409.
3. Pai, S.-Y., et al. Transplantation outcomes for severe combined immunodeficiency, 2000–2009. N. Engl. J. Med. 371 (2014), 434–446.
4. Brown, L., et al. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening. Blood 117 (2011), 3243–3246.
5. McGhee, S.A., Stiehm, E.R., McCabe, E.R.B., Potential costs and benefits of newborn screening for severe combined immunodeficiency. J. Pediatr. 147 (2005), 603–608.
6. Kwan, A., et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 312 (2014), 729–738.
7. Audrain, M., et al. Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single centre study. Clin. Immunol. 150 (2014), 137–139.
8. Chien, Y.-H., et al. Incidence of severe combined immunodeficiency through newborn screening in a Chinese population. J. Formos. Med. Assoc. 114 (2015), 12–16.
9. Olbrich, P., et al. A first pilot study on the neonatal screening of primary immunodeficiencies in Spain: TRECS and KRECS identify severe T- and B-cell lymphopaenia. An. Pediatría (English Ed.) 81 (2014), 310–317.
10. Adams, S.P., et al. Screening of neonatal UK dried blood spots using a duplex TREC screening assay. J. Clin. Immunol. 34 (2014), 323–330.
11. Kwan, A., et al. Successful newborn screening for SCID in the Navajo Nation. Clin. Immunol. 158 (2015), 29–34.
12. Gaspar, H.B., Hammarström, L., Mahlaoui, N., Borte, M., Borte, S., The case for mandatory newborn screening for severe combined immunodeficiency (SCID). J. Clin. Immunol. 34 (2014), 393–397.
13. Serana, F., et al. Thymic and bone marrow output in patients with common variable immunodeficiency. J. Clin. Immunol. 31 (2011), 540–549.
14. Centraal Bureau voor de Statistiek, CBS StatLine - Geboorte; kerncijfers. at http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=37422ned&D1=0,4-5,7,9,11,13,17,26,35,40-41&D2=0,10,20,30,40,(l-4)-l&HD=090218-0953&HDR=G1&STB=T, 2016.
15. Vogel, B.H., et al. Newborn screening for SCID in New York state: experience from the first two years. J. Clin. Immunol. 34 (2014), 289–303.
16. Verbsky, J.W., et al. Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008–2011). J. Clin. Immunol. 32 (2012), 82–88.
17. Routes, J.M., et al. Statewide newborn screening for severe T-cell lymphopenia. JAMA 302 (2009), 2465–2470.
18. Kwan, A., et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J. Allergy Clin. Immunol. 132 (2013), 140–150.e7.
19. Duffner, U., Optimizing newborn screening for severe combined immunodeficiency - the Michigan experience. Pediatrics, 131, 2013, 1298.
20. la Marca, G., et al. Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency. J. Allergy Clin. Immunol. 131 (2013), 1604–1610.
21. th of July. at http://artsenjgz.nl/nieuwsbericht/reactie-minister-van-vws-op-advies-gezondheidsraad-over-14-nieuwe-aandoeningen-in-de-hielprikscreening/>, 2015.